QCM Cayman’s Johnson & Johnson JNJ Stock Holding History

QCM Cayman’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,700	Closed	-$585K	–	282
2017 Q1	$585K	Buy	+4,700	New	+$561K	0.11%	181

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

QCM Cayman's JNJ Position: Q2 2023 in Review

QCM Cayman sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 1,838 shares — an estimated $285K sold.

QCM Cayman first reported a position in JNJ in Q4 2013 and held it in 7 quarters. The position peaked at $1.14M in Q1 2017. 3,751 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

QCM Cayman reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
QCM Cayman sold 1,838 Johnson & Johnson shares in Q2 2023, an estimated $285K.
QCM Cayman first reported a position in Johnson & Johnson in Q4 2013 and held it in 7 quarters.
QCM Cayman's Johnson & Johnson position peaked at $1.14M in Q1 2017.
3,751 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on QCM Cayman's 13F filing for Q2 2023, filed 25 Jul 2023.